Asensus Surgical to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference
01 Julho 2021 - 7:55AM
Business Wire
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
patient to pioneer a new era of Performance-Guided Surgery™,
announced today that Anthony Fernando, President and Chief
Executive Officer, and Shameze Rampertab, Executive Vice President
and Chief Financial Officer, will present at the Ladenburg Thalmann
2021 Virtual Healthcare Conference. The virtual presentation is
scheduled to take place at 8:30 am Eastern Time, Wednesday, July
14, 2021.
A live audio webcast of the conference presentation will be
available online on the investor relations page of the Company’s
website at https://ir.asensus.com/events-and-presentations. Replays
of the webcasts will be archived on the website for approximately
90 days.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking the clinical intelligence to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the
Senhance® Surgical System powered by the Intelligent Surgical Unit™
(ISU™) to increase surgeon control and reduce surgical variability.
With the addition of machine vision, augmented intelligence, and
deep learning capabilities throughout the surgical experience, we
intend to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the US, EU, Japan,
Russia, and select other countries. For a complete list of
indications for use, visit: www.senhance.com/indications. For more
information, visit www.asensus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210701005183/en/
INVESTOR CONTACT: Mark Klausner or Mike Vallie,
443-213-0499 invest@asensus.com or MEDIA CONTACT: Kristin
Schaeffer CG Life kschaeffer@cglife.com
Asensus Surgical, Inc. (NYSE:ASXC)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Asensus Surgical, Inc. (NYSE:ASXC)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
Notícias em tempo-real sobre Asensus Surgical, Inc. da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Asensus Surgical, Inc.